Riluzole for bipolar depression
About this title
Read the official source — NCT00376220Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Understand this study
What did researchers investigate?
Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 94
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00376220
- Official title
Show the full official title
A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Baltimore
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Did this study involve medication?
Yes. The study involved medication, including Riluzole.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
